2025 annual financial data
Trinity Biotech 2025 Operating margin
Direct answer
Operating margin was -26.07%.
Operating income was -11,416,000 USD and net income was -37,376,000 USD.
Operating cash flow was -5,929,000 USD.
Get free Trinity Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 43,785,000 USD
- Operating income
- -11,416,000 USD
- Net income
- -37,376,000 USD
- Operating cash flow
- -5,929,000 USD